Navigation Links
Golden Meditech Increase Stake in NYSE-listed Affiliate - China Cord Blood Corporation to 40.9%
Date:9/28/2011

HONG KONG, Sept. 28, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," - 801.HK; 910801.TW), China's leading integrated healthcare enterprise, today announced that the Group has continued to increase its ownership in its NYSE-listed affiliate, China Cord Blood Corporation ("CCBC," – CO.US) from the open market.  As a result of which the Group now owns 40.9% of the issued share capital of CCBC from the previous 39.5%. 

CCBC is the largest cord blood banking operator in China and is the only one with multiple exclusive licenses including Beijing Municipal, Guangdong Province and Zhejiang Province, with approximately 20% stake in the exclusive operator in Shandong Province. 

Mr. Kam YUEN, Chairman and Chief Executive Officer of the Group, said, "We are proud to see that CCBC has sustained strong steady growth and profitability in its initial markets in Beijing and Guangdong while continuously deliver positive news on new market expansions since its initial public offering.  As the founding and largest shareholder of CCBC, we remain optimistic of CCBC's prospects in both China and Asia Pacific and are duly confident in the capability of its management team.  We see considerable room for CCBC to further enhance market penetration with steady growth and market development."

Under the "one-license-per-region" regulatory framework, the government has issued seven exclusive operating licenses thus far.  The strategic coverage of CCBC's current operation in Beijing, Zhejiang and Guangdong has enabled it to capture key strategic economic strongholds in the affluent eastern coastline of China.

About Golden Meditech Holdings LimitedGolden Meditech Holdings Limited is China's leading integrated-healthcare devices and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx) and the Taiwan Stock Exchange (TSE).  Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities.  Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.Investor Relations DepartmentGolden Meditech Holdings LimitedAddress:
48/F, Bank of China Tower, 1 Garden Road, Central, Hong KongTel:
+852 3605 8180Fax:
+852 3605 8181Email:
ir@goldenmeditech.com  
'/>"/>

SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Meditech Disposes of 2.0% Stake in FunTalk China for US$15 Million
2. Golden Meditech Celebrates Grand Opening of Taiwan Representative Office
3. Golden Meditech FY2010-11 Annual Results
4. Golden Meditech Acquires Shanghai East International Medical Centre
5. Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
6. Golden Meditech Chairman Increases Stake in Company
7. Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China
8. Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business
9. Golden Meditech to Form Strategic Alliance with Long Bon International
10. Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
11. Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 2016 The pen needles market is projected ... 1.65 billion in 2016, growing at a CAGR of ... Over the years, the pen needles market has ... the growing demand for safety injections in the healthcare ... safety pen needles with an aim to reduce pain, ...
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... 6, 2016  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... focused on the development of novel therapies for ... U.S. Food and Drug Administration (FDA) has granted ... of X-linked adrenoleukodystrophy (X-ALD).  VK0214 is a novel, ... selectively regulates the expression of genes believed to ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... ... AlignLife clinics nationwide are giving back to their communities by collecting toys ... gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread the joy ... In exchange for generous donations, customers will receive a gift in return. Anyone ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... 07, 2016 , ... "ProBrand Flip allows FCPX editors to create unique logo ... CEO of Pixel Film Studios. , ProBrand Flip includes 30 flip book reveal animations. ... select from a variety of flip book animations. In Addition, users can modify each ...
(Date:12/7/2016)... ... ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration depicting the first ... Trump Goes To Washington” is the creation of published author, Nancy Engestrom, a hardworking ... attributes her patriotic nature to her WWII veteran father. She says, “I love ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... was honored to present at the International Probiotic Association’s Washington DC workshop on ... government regulators to engage in dialog regarding probiotic dietary supplement regulations. , ...
Breaking Medicine News(10 mins):